Status:
RECRUITING
The Effect of Treatment of Emphysema With Endobronchial Valves on the Diaphragm Mobility
Lead Sponsor:
Aarhus University Hospital
Conditions:
Chronic Obstructive Pulmonary Disease
Emphysema or COPD
Eligibility:
All Genders
18+ years
Brief Summary
In some patients with chronic obstructive pulmonary disease (COPD) the breathlessness is caused by hyperinflation of the lungs. This causes difficulty breathing air out and makes it harder to breath i...
Detailed Description
When emphysema is present in COPD-patients, the impaired expiratory ventilation causes lung hyperinflation. This results in a change in the respiratory mechanisms of the thorax and thereby impairment ...
Eligibility Criteria
Inclusion
- Patients selected to receive treatment with endobronchial valves
- Signed informed consent
Exclusion
- Neuromuscular disease interfering with diaphragm function
- Pleural effusion at time of preoperative or 90-days postoperative ultrasound
Key Trial Info
Start Date :
November 27 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06163131
Start Date
November 27 2023
End Date
April 1 2027
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark, 8200